Evaluation of the treatment efficacy with adalimumab in Crohn's disease - case report

被引：0

作者：

Eder, Piotr ^{[1
]}

Lykowska-Szuber, Liliana ^{[1
]}

Krela-Kazmierczak, Iwona ^{[1
]}

Iwanik, Katarzyna ^{[2
]}

Karmelita-Katulska, Katarzyna ^{[3
]}

Majewski, Przemyslaw ^{[2
]}

Linke, Krzysztof ^{[1
]}

机构：

[1] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra & Klin Gastroenterol Zywienia Czlowieka &, Poznan, Poland

[2] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra & Zaklad Patomorfol Klin, Poznan, Poland

[3] Uniwersytetu Med Karola Marcinkowskiego Poznaniu, Katedra Radiol, Poznan, Poland

来源：

PRZEGLAD GASTROENTEROLOGICZNY | 2010年 / 5卷 / 01期

关键词：

Crohn's disease; adalimumab; mucosal healing; VALIDATION; INFLIXIMAB;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Usage of anti-TNF-alpha agents in Crohn's disease is one of the most important therapeutic achievements in Gastroenterology over the last few years. Unfortunately there is still a lack of evidence on how to assess objectively the performance of this biological therapy. In this paper we present a case study of a patient treated with adalimumab, in which we assessed the efficacy of the treatment relying not only on the clinical indices and laboratory markers, but also on endoscopic, histological, and radiological methods.

引用

页码：47 / 51

页数：5

共 8 条

[1] Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD [J].